CCS
STML

Crosspoint Capital Strategies’s Stemline Therapeutics, Inc. STML Stock Holding History

Crosspoint Capital Strategies’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
2017
Q4 		$1.03M Hold
2017
Q3 		$73K Hold
2017
Q2 		$61K Buy